Purchases and Sales Made in Q4 2024 in Protagonist Therapeutics, Inc (PTGX)
This table provides information about the institutional ownership of Protagonist Therapeutics, Inc (PTGX) during Q4 2024. The information is specifically focused on institutions that hold shares of Protagonist Therapeutics, Inc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2025
Q4 2024
|
Mangrove Partners
New York, NY |
SELL
|
- |
-43.9K- 10.0% |
$1.69M - $2.13M
|
395K
$21.7M
|
|
|
Jan 22, 2025
Q4 2024
|
Moody Aldrich Partners LLC
|
SELL
|
- |
-51.9K- 43.49% |
$2M - $2.51M
|
67.4K
$3.71M
|
|
|
Feb 11, 2025
Q4 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-63.2K- 7.69% |
$2.43M - $3.06M
|
759K
$41.7M
|
|
|
Feb 14, 2025
Q4 2024
|
Kynam Capital Management, LP
Princeton, NJ |
SELL
|
- |
-65.6K- 14.37% |
$2.53M - $3.18M
|
391K
$21.5M
|
|
|
Feb 14, 2025
Q4 2024
|
Ubs Asset Management Americas Inc
Chicago, IL |
SELL
|
- |
-80.2K- 21.79% |
$3.09M - $3.89M
|
288K
$15.8M
|
|
|
Feb 14, 2025
Q4 2024
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-80.9K- 34.85% |
$3.11M - $3.92M
|
151K
$8.31M
|
|
|
Feb 14, 2025
Q4 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-88.3K- 14.05% |
$3.4M - $4.28M
|
540K
$29.7M
|
|
|
Jan 29, 2025
Q4 2024
|
Allspring Global Investments Holdings, LLC
|
SELL
|
- |
-97.9K- 94.25% |
$3.77M - $4.74M
|
5.98K
$329K
|
|
|
Feb 14, 2025
Q4 2024
|
Algert Global LLC
San Francisco, CA |
SELL
|
- |
-98K- 84.68% |
$3.77M - $4.74M
|
17.7K
$974K
|
|
|
Feb 14, 2025
Q4 2024
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-103K- 7.49% |
$3.96M - $4.98M
|
1.27M
$69.9M
|
|
|
Feb 14, 2025
Q4 2024
|
Driehaus Capital Management LLC
Chicago, IL |
SELL
|
- |
-106K- 23.72% |
$4.07M - $5.12M
|
340K
$18.7M
|
|
|
Feb 13, 2025
Q4 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-296K- 93.75% |
$11.4M - $14.3M
|
19.7K
$1.08M
|
|
|
Feb 14, 2025
Q4 2024
|
Jefferies Financial Group Inc.
New York, NY |
SELL
|
- |
-325K- 17.92% |
$12.5M - $15.7M
|
1.49M
$81.9M
|